Our study has demonstrated that, likely owing to a concomitant reduction in expression of the migratory protein β1-integrin, antagonism or knockdown of JAM-A in MCF7 human breast cancer epithelial cells significantly decreases cell migration [20]. The gene discussed is F11R; the disease is breast carcinoma.